Pharmaceutic Litho & Label Company, a portfolio company of Saugatuck Capital, has acquired Plymouth Printing Company. Pharmaceutic Litho has been a portfolio company of Saugatuck since October 2014. The equity to acquire Plymouth was provided by Saugatuck Capital Company IX. First Niagara Bank and Ironwood Capital – both current lenders to Pharmaceutic Litho – provided additional debt financing for the transaction.
Plymouth provides printing and packaging services to the healthcare and pharmaceutical industries. The company’s printing and packaging capabilities include roll inserts; folded or glued inserts and outserts; pressure sensitive or heat seal roll labels; and pouch, blister, and lidding materials. Plymouth was founded in 1928 by J.S. Auerbach and is headquartered near Newark in Cranford, NJ. The company also has a production facility in Winston-Salem, NC (www.plymouthprinting.com).
Pharmaceutic Litho is a maker of labels, inserts and outserts, booklets, and manuals used in the pharmaceutical, biotech, and medical device industries. The company was founded in 1964 and is based near Los Angeles in Simi Valley, CA (www.pharmaceuticlitho.com).
Saugatuck Capital invests in leveraged recapitalizations, buyouts, and growth equity investments in the lower middle-market. Saugatuck seeks companies with revenues of $15 million to $125 million in fragmented service and manufacturing industries. The firm was founded in 1982 and is based in Wilton, CT (www.saugatuckcapital.com).
© 2015 PEPD • Private Equity’s Leading News Magazine • 12-1-15